These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9547584)

  • 1. Negative growth regulation of oncogene-transformed mammary epithelial cells by tumor inhibitors.
    Telang NT; Inoue S; Bradlow HL; Osborne MP
    Adv Exp Med Biol; 1997; 400A():409-18. PubMed ID: 9547584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent estrogen responsiveness of ras oncogene-transformed mouse mammary epithelial cells.
    Suto A; Bradlow HL; Wong GY; Osborne MP; Telang NT
    Steroids; 1992 Jun; 57(6):262-8. PubMed ID: 1440696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of mammary preneoplasia. In vitro effects of a green tea polyphenol.
    Araki R; Inoue S; Osborne MP; Telang NT
    Ann N Y Acad Sci; 1995 Sep; 768():215-22. PubMed ID: 8526351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tamoxifen on mammary preneoplasia: relevance to chemopreventive intervention.
    Telang NT; Bradlow HL; Osborne MP
    Cancer Detect Prev; 1994; 18(4):313-21. PubMed ID: 7982241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinated expression of intermediate biomarkers for tumorigenic transformation in RAS-transfected mouse mammary epithelial cells.
    Telang NT; Narayanan R; Bradlow HL; Osborne MP
    Breast Cancer Res Treat; 1991 Aug; 18(3):155-63. PubMed ID: 1756258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells.
    Suto A; Bradlow HL; Wong GY; Osborne MP; Telang NT
    Breast Cancer Res Treat; 1993 Sep; 27(3):193-202. PubMed ID: 8312577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and endocrine biomarkers in non-involved breast: relevance to cancer chemoprevention.
    Telang NT; Bradlow HL; Osborne MP
    J Cell Biochem Suppl; 1992; 16G():161-9. PubMed ID: 1469896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preneoplastic transformation in mouse mammary tissue: identification and validation of intermediate biomarkers for chemoprevention.
    Telang NT; Kurihara H; Wong GY; Bradlow HL; Osborne MP
    Anticancer Res; 1991; 11(3):1021-7. PubMed ID: 1909512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of mammary preneoplastic transformation by naturally-occurring tumor inhibitors.
    Katdare M; Singhal H; Newmark H; Osborne MP; Telang NT
    Cancer Lett; 1997 Jan; 111(1-2):141-7. PubMed ID: 9022139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells.
    Medina D; Kittrell FS; Oborn CJ; Schwartz M
    Cancer Res; 1993 Feb; 53(3):668-74. PubMed ID: 8425201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the oncogenes mil and ras abolishes the in vivo differentiation of mammary epithelial cells.
    Günzburg WH; Salmons B; Schlaeffli A; Moritz-Legrand S; Jones W; Sarkar NH; Ullrich R
    Carcinogenesis; 1988 Oct; 9(10):1849-56. PubMed ID: 3048764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of oestradiol metabolism in myc oncogene-transfected mouse mammary epithelial cells.
    Telang NT; Arcuri F; Granata OM; Bradlow HL; Osborne MP; Castagnetta L
    Br J Cancer; 1998 May; 77(10):1549-54. PubMed ID: 9635827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of proliferation and modulation of estradiol metabolism: novel mechanisms for breast cancer prevention by the phytochemical indole-3-carbinol.
    Telang NT; Katdare M; Bradlow HL; Osborne MP; Fishman J
    Proc Soc Exp Biol Med; 1997 Nov; 216(2):246-52. PubMed ID: 9349693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
    Amundadottir LT; Leder P
    Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of aberrant proliferation and induction of apoptosis in pre-neoplastic human mammary epithelial cells by natural phytochemicals.
    Katdare M; Osborne MP; Telang NT
    Oncol Rep; 1998; 5(2):311-5. PubMed ID: 9468547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration in proliferative and endocrine responsiveness of human mammary carcinoma cells by prototypic tumor-suppressing agents.
    Suto A; Bradlow HL; Kubota T; Kitajima M; Wong GY; Osborne MP; Telang NT
    Steroids; 1993 May; 58(5):215-9. PubMed ID: 8356573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide.
    Jinno H; Steiner MG; Mehta RG; Osborne MP; Telang NT
    Carcinogenesis; 1999 Feb; 20(2):229-36. PubMed ID: 10069458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen inhibition of estrogen receptor-alpha-negative mouse mammary tumorigenesis.
    Medina D; Kittrell FS; Hill J; Shepard A; Thordarson G; Brown P
    Cancer Res; 2005 Apr; 65(8):3493-6. PubMed ID: 15833886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells.
    Telang NT; Suto A; Wong GY; Osborne MP; Bradlow HL
    J Natl Cancer Inst; 1992 Apr; 84(8):634-8. PubMed ID: 1556774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
    Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
    Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.